Embracing all the myriad variations of the human genome should, in theory, lead to rewards that all can share.
The FDA granted accelerated approval to Lartruvo (olaratumab) for patients with soft-tissue sarcoma based on results of a randomized clinical trial.
The role of payments to hospitals and physicians is not well understood, despite attempts to quantify them.
Appropriate sunscreen use may effectively prevent skin cancer, but studies to date have not taken proper application of sunscreen into account.
Researchers are identifying new roles for infectious and commensal microbes in facilitating and inhibiting carcinogenesis.
Prostate-specific antigen screening is not meaningfully less frequent than before guidelines were issued against use of the test.
Some data suggest esophageal cancer may be more common among patients diagnosed with achalasia, but there are no relevant screening guidelines.
Research and treatment of myeloma are beginning to focus on quality of life in addition to survival.
Population-wide care ought to be optimal, regardless of region, argue the authors of a recent study.
At War on Cancer, numerous figures in cancer care discussed innovations to reduce the costs associated with drugs.
After a litany of failures for immunotherapies against prostate cancer, calls are mounting for approaches that combine these agents with other treatments.
Publication of all data is critical to ensure the forward movement of research that is needed to create clinically meaningful improvement in patient outcomes.
Adopting a more healthful lifestyle, including reducing alcohol intake, can help breast cancer survivors avoid disease recurrence.
A recent study linked childhood height to risk of melanoma, but the findings should be interpreted with caution.
Contrary to some news headlines, monitoring prostate cancer has different survival implications than treatment after 10 years.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- The Role of Microbes in Oncogenesis and the Treatment of Cancer
- Despite USPSTF Recommendation, PSA Screening Sticking Around
- The Undetermined Role of Sunscreen in Skin Cancer Prevention
- No Overall Survival Difference Between Afatinib, Gefitinib in EGFR+ NSCLC
- More Favorable Prognosis With Left-sided Tumors in Colorectal Cancer